<DOC>
	<DOC>NCT01990040</DOC>
	<brief_summary>This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for patients with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in patients with SBS. SBS patients treated and not treated with teduglutide will be enrolled.</brief_summary>
	<brief_title>A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<criteria>This is an observational registry study. Data will be collected during routine consultations and clinical staff will enter this information into a system at baseline (when a patient consents into the study) and approximately every 6 months following. Each patient will be followed for at least 10 years.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Short Bowel Syndrome</keyword>
	<keyword>SBS</keyword>
	<keyword>teduglutide</keyword>
	<keyword>Gattex</keyword>
</DOC>